The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase
Antimicrobial Agents and Chemotherapy · 30.04.2024
DOI: 10.1128/aac.00054-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 30.04.2024. Verfasst von Yongkang Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Scienc…. Hauptthemen laut MEDLINE: Virus Replication, Antiviral Agents, Enterovirus, RNA-Dependent RNA Polymerase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Shanghai Municipal Science and Technology Major Project, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Human enteroviruses are the major pathogens causing hand-foot-and-mouth disease in infants and young children throughout the world, and infection with enterovirus is also associated with severe complications, such as aseptic meningitis and myocarditis. However, there are no antiviral drugs available to treat enteroviruses infection at present. In this study, we found that 4′-fluorouridine (4′-FlU), a nucleoside analog with low cytotoxicity, exhibited broad-spectrum activity against infections of multiple enteroviruses with EC50 values at low micromolar levels, including coxsackievirus A10 (CV-A10), CV-A16, CV-A6, CV-A7, CV-B3, enterovirus A71 (EV-A71), EV-A89, EV-D68, and echovirus 6. With further investigation, the results indicated that 4′-FlU directly interacted with the RNA-dependent RNA polymerase of enterovirus, the 3D pol , and impaired the polymerase activity of 3D pol , hence inhibiting viral RNA synthesis and significantly suppressing viral replication. Our findings suggest that 4′-FlU could be promisingly developed as a broad-spectrum direct-acting antiviral agent for anti-enteroviruses therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shang…
- Clinical Center for BioTherapy, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Yongkang Chen, Shuye Zhang, Lu Lu, Peng Zou
Förderung
- National Key R&D Program of China
- Shanghai Municipal Science and Technology Major Project
- National Natural Science Foundation of China (NSFC)
- Shanghai Public Health Clinical Center
Zitieren
APA
Chen, Y., Li, X., Han, F., Ji, B., Li, Y., Yan, J., Wang, M., Fan, J., Zhang, S., Lu, L., & Zou, P. (2024). The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00054-24
Vancouver
Chen Y, Li X, Han F, Ji B, Li Y, Yan J, et al. The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00054-24
BibTeX
@article{Chen2024,
author = {Chen, Yongkang and Li, Xiaohong and Han, Fengyang and Ji, Beihong and Li, Yuan and Yan, Jingjing and Wang, Min and Fan, Jun and Zhang, Shuye and Lu, Lu and Zou, Peng},
title = {The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00054-24}
}
EUVIMED